Trials / Completed
CompletedNCT04555863
haMSter: a Novel Smartphone Communication Tool for People With MS
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone. Endpoints include the adherence to this app and satisfaction with this Intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | haMSter smartphone app | the app tracks patient reported outcomes |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-04-01
- Completion
- 2021-06-01
- First posted
- 2020-09-21
- Last updated
- 2021-10-13
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04555863. Inclusion in this directory is not an endorsement.